Digital Tools-Regulatory Considerations for Application in Clinical Trials.
PMID: 37195515 ·
L, i, a, n, , G, e, l, i, s, ;, , I, s, a, b, e, l, l, e, , S, t, o, e, c, k, e, r, t, ;, , H, a, n, s, -, P, e, t, e, r, , P, o, d, h, a, i, s, k, y
Реклама
Аннотация
During the last few years, the pharmaceutical industry has adopted digital technologies/digital health technology (DHT) to improve the drug development process and the commercialization of new products. Technological advances are strongly supported by both the US-FDA and the EMA, but the regulatory landscape in the US seems to be more suitable to promote innovation in the digital health sector (e.g. Cures Act). In contrast, the new Medical Device Regulation sets high hurdles for Medical Device s
Реклама
Официальный источник
Открыть в PubMed →Данные получены из PubMed / NCBI. Полный текст и наиболее актуальную информацию всегда смотрите в официальной записи.